Valuation dashboard for Outset Medical, Inc. (OM) with P/E N/A, P/B 0.59, EV/EBITDA -2.42 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.
Analysis Summary
Outset Medical, Inc. reported revenue of $119.5M in the most recent fiscal year, growing at a 5-year CAGR of 19.1%.
Trailing-twelve-month margins: gross margin 41.8%, operating margin -56.1%, net margin -63.1%.
At the current price of $3.10, OM has negative trailing earnings (P/E not meaningful) and an ROE of -62.25%. Market capitalisation stands at $57M.
Balance sheet quality for OM: current ratio of 6.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -2.42 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-67.74 |
| vs Current Price | -2285.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| OM | Outset Medical, Inc. | $57M | 0.59 | -62.3% | |
| ABT | Abbott Laboratories | $176.8B | 32.91 | 3.49 | 10.5% |
| 0Y6X.L | Medtronic Plc | $121.8B | |||
| MDT | Medtronic plc | $120.0B | 22.68 | 2.36 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 28.79 | 4.48 | 16.4% |
| 0R2S.L | Stryker Corporation | $105.5B | 28.60 | 4.45 | 16.4% |
| BSX | Boston Scientific Corporation | $65.2B | 17.71 | 2.60 | 14.9% |
| 0HOY.L | Boston Scientific Corporation | $64.6B | 47.45 | 5.68 | 11.9% |
Price
| Price | $3.10 |
| Market Cap | $57M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -62.25% |
| Return on Invested Capital | -32.84% |
| Return on Assets | -30.65% |
| Gross Margin | 41.76% |
| Operating Margin | -56.06% |
| Net Margin | -63.06% |
Related companies: CATX · HSDT · INGN · NNOX · OMI · QTRX · SI
Explore sector: Healthcare · Medical - Devices
More sections of OM: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks